Tracking the use of commercial fibrin sealants
When the inquiring pathologist first became medical director of the Tissue Bank at her institution, Tisseel® fibrin sealant a commercial product) was being tracked as a tissue. The inquiring pathologist is assuming that her hospital was tracking this commercial fibrin sealant's use because it is derived from human plasma and therefore in theory potentially infectious. However, she is unaware of any reports of viral transmission, the product goes through an inactivation (sterilization) process, and the product can be obtained from non-tissue bank establishments. She asks "Is it therfore safe to say that a commercial fibrin sealent, such as Tisseel® fibrin sealant, is not considered a tissue?"
Ira A. Shulman, MD
CBBS e-Network Forum Editor & Moderator
W. Tait Stevens, MD
CBBS e-Network Forum Assistant Editor & Moderator
The e-Network Forum is supported in part by the California Blood Bank Society (CBBS) and the American Red Cross Blood Services (ARCBS) and endorses collegial discussion among blood banking and transfusion medicine professionals. However, neither the CBBS nor the ARCBS in any way endorse the specific views and opinions expressed in the forum. The forum is not intended as a substitute for medical or legal advice and the content should not be relied upon for any medical or legal purposes. Readers should make their own determinations as to: (i) what constitutes appropriate medical, technical, and administrative practices, and (ii) how best to comply with laws and regulations relevant to their questions. For the latter, they should consider consulting, as to any medical matters, a qualified physician, and, as to any legal matters, an attorney familiar with related state and federal laws. The user of the forum, by accessing same, assumes all risks arising out of such use and releases CBBS and their respective members, directors, officers and agents from and against any loss, damage, claim or liability arising out of such use of the Forum.